Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Rapidly growing tumor cells require a nutrient-rich environment in order to thrive, therefore, restricting access to certain key amino acids, such as arginine, often results in the death of malignant cells, which frequently display defective cell cycle check-point control. Healthy cells, by contrast...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6d0e88b6c8394e96a192ccd3dd287118 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6d0e88b6c8394e96a192ccd3dd287118 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6d0e88b6c8394e96a192ccd3dd2871182021-11-18T08:00:02ZArginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.1932-620310.1371/journal.pone.0054464https://doaj.org/article/6d0e88b6c8394e96a192ccd3dd2871182013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23365669/?tool=EBIhttps://doaj.org/toc/1932-6203Rapidly growing tumor cells require a nutrient-rich environment in order to thrive, therefore, restricting access to certain key amino acids, such as arginine, often results in the death of malignant cells, which frequently display defective cell cycle check-point control. Healthy cells, by contrast, become quiescent and remain viable under arginine restriction, displaying full recovery upon return to arginine-rich conditions. The use of arginase therapy to restrict available arginine for selectively targeting malignant cells is currently under investigation in human clinical trials. However, the suitability of this approach for veterinary uses is unexplored. As a prelude to in vivo studies in canine malignancies, we examined the in vitro effects of arginine-deprivation on canine lymphoid and osteosarcoma cell lines. Two lymphoid and 2 osteosarcoma cell lines were unable to recover following 6 days of arginine deprivation, but all remaining cell lines displayed full recovery upon return to arginine-rich culture conditions. These remaining cell lines all proved susceptible to cell death following the addition of arginase to the cultures. The lymphoid lines were particularly sensitive to arginase, becoming unrecoverable after just 3 days of treatment. Two of the osteosarcoma lines were also susceptible over this time-frame; however the other 3 lines required 6-8 days of arginase treatment to prevent recovery. In contrast, adult progenitor cells from the bone marrow of a healthy dog were able to recover fully following 9 days of culture in arginase. Over 3 days in culture, arginase was more effective than asparaginase in inducing the death of lymphoid lines. These results strongly suggest that short-term arginase treatment warrants further investigation as a therapy for lymphoid malignancies and osteosarcomas in dogs.James W WellsChristopher H EvansMilcah C ScottBarbara C RütgenTimothy D O'BrienJaime F ModianoGoran CvetkovicSlobodan TepicPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 1, p e54464 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q James W Wells Christopher H Evans Milcah C Scott Barbara C Rütgen Timothy D O'Brien Jaime F Modiano Goran Cvetkovic Slobodan Tepic Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| description |
Rapidly growing tumor cells require a nutrient-rich environment in order to thrive, therefore, restricting access to certain key amino acids, such as arginine, often results in the death of malignant cells, which frequently display defective cell cycle check-point control. Healthy cells, by contrast, become quiescent and remain viable under arginine restriction, displaying full recovery upon return to arginine-rich conditions. The use of arginase therapy to restrict available arginine for selectively targeting malignant cells is currently under investigation in human clinical trials. However, the suitability of this approach for veterinary uses is unexplored. As a prelude to in vivo studies in canine malignancies, we examined the in vitro effects of arginine-deprivation on canine lymphoid and osteosarcoma cell lines. Two lymphoid and 2 osteosarcoma cell lines were unable to recover following 6 days of arginine deprivation, but all remaining cell lines displayed full recovery upon return to arginine-rich culture conditions. These remaining cell lines all proved susceptible to cell death following the addition of arginase to the cultures. The lymphoid lines were particularly sensitive to arginase, becoming unrecoverable after just 3 days of treatment. Two of the osteosarcoma lines were also susceptible over this time-frame; however the other 3 lines required 6-8 days of arginase treatment to prevent recovery. In contrast, adult progenitor cells from the bone marrow of a healthy dog were able to recover fully following 9 days of culture in arginase. Over 3 days in culture, arginase was more effective than asparaginase in inducing the death of lymphoid lines. These results strongly suggest that short-term arginase treatment warrants further investigation as a therapy for lymphoid malignancies and osteosarcomas in dogs. |
| format |
article |
| author |
James W Wells Christopher H Evans Milcah C Scott Barbara C Rütgen Timothy D O'Brien Jaime F Modiano Goran Cvetkovic Slobodan Tepic |
| author_facet |
James W Wells Christopher H Evans Milcah C Scott Barbara C Rütgen Timothy D O'Brien Jaime F Modiano Goran Cvetkovic Slobodan Tepic |
| author_sort |
James W Wells |
| title |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| title_short |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| title_full |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| title_fullStr |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| title_full_unstemmed |
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| title_sort |
arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/6d0e88b6c8394e96a192ccd3dd287118 |
| work_keys_str_mv |
AT jameswwells arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT christopherhevans arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT milcahcscott arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT barbaracrutgen arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT timothydobrien arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT jaimefmodiano arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT gorancvetkovic arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation AT slobodantepic arginasetreatmentpreventstherecoveryofcaninelymphomaandosteosarcomacellsresistanttothetoxiceffectsofprolongedargininedeprivation |
| _version_ |
1718422671247540224 |